DE GIORGIS, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.463
AS - Asia 1.744
EU - Europa 1.500
SA - Sud America 253
AF - Africa 49
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.014
Nazione #
US - Stati Uniti d'America 2.372
CN - Cina 626
SG - Singapore 544
IE - Irlanda 340
RU - Federazione Russa 321
HK - Hong Kong 300
DE - Germania 222
BR - Brasile 212
IT - Italia 174
FI - Finlandia 142
GB - Regno Unito 89
VN - Vietnam 89
CA - Canada 50
IN - India 45
JP - Giappone 33
MX - Messico 32
SE - Svezia 32
ZA - Sudafrica 27
PL - Polonia 25
UA - Ucraina 24
BD - Bangladesh 23
FR - Francia 21
NL - Olanda 21
AR - Argentina 20
ES - Italia 20
LT - Lituania 16
AT - Austria 15
IQ - Iraq 12
TR - Turchia 12
PK - Pakistan 10
BE - Belgio 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CH - Svizzera 5
ID - Indonesia 5
MA - Marocco 5
PY - Paraguay 5
DK - Danimarca 4
EC - Ecuador 4
KE - Kenya 4
LB - Libano 4
LK - Sri Lanka 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AO - Angola 2
BO - Bolivia 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.014
Città #
Dublin 340
Chandler 331
Dallas 306
Hong Kong 297
Singapore 246
Beijing 228
Ashburn 219
New York 122
Los Angeles 109
Munich 103
Boardman 82
Helsinki 72
Moscow 57
Redondo Beach 55
Turku 51
Shanghai 50
Medford 47
Lawrence 46
Princeton 46
Nanjing 37
São Paulo 36
Ho Chi Minh City 35
Wilmington 33
Tokyo 31
Denver 29
Falkenstein 29
Jacksonville 29
Milan 28
Buffalo 25
Pavia 25
Mexico City 24
Stockholm 24
Warsaw 24
Brooklyn 23
Chicago 23
Johannesburg 23
Santa Clara 23
Nuremberg 21
Chennai 20
Nanchang 20
Orem 19
Montreal 18
Ann Arbor 17
Changsha 17
Hanoi 17
London 15
Poplar 15
Manchester 14
Shenyang 14
Frankfurt am Main 13
Houston 13
Piscataway 13
The Dalles 13
Amsterdam 12
Seattle 12
Toronto 12
Hebei 11
Phoenix 11
Rome 11
Atlanta 10
Falls Church 10
Tianjin 10
Boston 9
Düsseldorf 9
Jiaxing 9
Secaucus 9
Washington 9
Ankara 8
Turin 8
Brescia 7
Guangzhou 7
Hangzhou 7
Rio de Janeiro 7
Brussels 6
Curitiba 6
Fairfield 6
Mumbai 6
Tashkent 6
Vienna 6
Baghdad 5
Baku 5
Belo Horizonte 5
Campinas 5
Columbus 5
Da Nang 5
Dearborn 5
Dhaka 5
Norwalk 5
Salt Lake City 5
San Francisco 5
Vancouver 5
Charlotte 4
Chongqing 4
Colombo 4
Hyderabad 4
Lauterbourg 4
Monza 4
New Delhi 4
Porto Alegre 4
San Jose 4
Totale 3.887
Nome #
Atypical Manifestations in Glut1 Deficiency Syndrome 110
Arterial spin labelling qualitative assessment in paediatric patients with MRI-negative epilepsy 100
Encephalopathies with intracranial calcification in children: Clinical and genetic characterization 99
The epileptology of Aicardi-Goutières syndrome: electro-clinical-radiological findings 99
ANDAMENTO DELL’INDICE GLUCO-CHETONICO IN CORSO DI TRATTAMENTO DIEPILESSIA REFRATTARIA CON DIETA CHETOGENICA 97
Basal Ganglia Dysmorphism in Patients With Aicardi Syndrome 97
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 95
Early-onset movement disorder as diagnostic marker in genetic syndromes: Three cases of FOXG1-related syndrome 95
Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review 95
Comment on: Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations 93
Quality of life in chronic ketogenic diet treatment: she GLUT1DS population perspective 92
Impact of the inversion time on regional brain perfusion estimation with clinical arterial spin labeling protocols 92
Families' Perception of Classic Ketogenic Diet Management in Acute Medical Conditions: A Web-Based Survey 90
Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy 89
Post-operative benefits of animal-assisted therapy in pediatric surgery: a randomised study. 88
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform 86
Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome 86
The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus 85
Impact of the ketogenic diet on linear growth in children: A single-center retrospective analysis of 34 cases 85
Family Dysfunctional Interactive Patterns and Alexithymia in Adolescent Patients with Restrictive Eating Disorders 83
Genetic and phenotypic spectrum associated with IFIH1 gain-of-function 83
Developmental Outcomes of Aicardi Goutières Syndrome 81
Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features 79
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform 76
Commentary on “Catatonia in a Patient with Aicardi-Goutières Syndrome Efficiently Treated with Immunoadsorption” 76
Ketogenic Dietary Therapies in Patients with Autism Spectrum Disorder: Facts or Fads? A Scoping Review and a Proposal for a Shared Protocol 74
The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: An Italian consensus 72
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 72
Novel insight into GLUT1 Deficiency Syndrome: screening for emotional and behavioral problems in youths following ketogenic diet 71
Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique 70
Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome 70
Development of a neurologic severity scale for Aicardi Goutières Syndrome 70
Classic ketogenic diet in parenteral nutrition in a GLUT1DS patient: Doing more with less in an acute surgical setting 68
Diagnostic yield and cost-effectiveness of “dynamic” exome analysis in epilepsy with neurodevelopmental disorders: A tertiary-center experience in Northern Italy 68
Characterization of speech and language phenotype in GLUT1DS 68
Systematic review of executive functions in children with self-limited epilepsy with centrotemporal spikes 68
Short-term effects of ketogenic diet on anthropometric parameters, body fat distribution, and inflammatory cytokine production in GLUT1 deficiency syndrome 67
Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype 67
Use of remote monitoring by E-mail for long-term management of the classic ketogenic diet 66
Long-term effects of the ketogenic diet on growth in children with resistant drug epilepsy and Glucose Transporter Type 1 Deficiency Syndrome 62
The effect of executive function on health related quality of life in children with self-limited epilepsy with centrotemporal spikes 61
The changing face of dietary therapy for epilepsy 61
Glucose transporter 1 deficiency syndrome: nutritional and growth pattern phenotypes at diagnosis 61
Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy 61
Blindness affects the developmental trajectory of the sleeping brain 60
On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva 59
Ketonemia variability through menstrual cycle in patients undergoing classic ketogenic diet 58
Aicardi Syndrome: Key Fetal MRI Features and Prenatal Differential Diagnosis 57
Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease 57
One Month of Classic Therapeutic Ketogenic Diet Decreases Short Chain Fatty Acids Production in Epileptic Patients 57
Sleep effects of Ketogenic diet in pediatric patients with migraine: Preliminary data of a prospective study 56
A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy 55
Studio policentrico retrospettivo sulle epilessie ad esordio nel primo anno di vita finalizzato alla elaborazione di percorsi diagnostici e linee guida 55
Cerebellar heterotopia in an 11-year-old child with KDM6B-related neurodevelopmental disorder: A case report and review of the literature 54
Genetic Epilepsies and Developmental Epileptic Encephalopathies with Early Onset: A Multicenter Study 52
Novel insights into the clinico-radiological spectrum of phenotypes associated to PIGN mutations 52
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 51
EEG at onset and MRI predict long-term clinical outcome in Aicardi syndrome 51
Breakdown or Personality Disorder? Psychiatric Characterization and Developmental Pathways Towards Young Adulthood in Adolescents with Pathological Personality Structure 51
Long-term effects of a classic ketogenic diet on ghrelin and leptin concentration: A 12-month prospective study in a cohort of italian children and adults with GLUT1-deficiency syndrome and drug resistant epilepsy 51
Adherence to ketogenic dietary therapies in epilepsy: A systematic review of literature 51
Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet 50
GLUT1DS focus on dysarthria 49
Neuroradiologic, clinic and genetic characterization of cerebellar heterotopia: a pediatric multicentric study 48
Acute chorea in a child receiving second dose of human papilloma virus vaccine 48
Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience 48
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study 48
Family Dysfunctional Interactive Patterns and Alexithymia in Adolescent Patients with Restrictive Eating Disorders 46
Pathways to quality of life in adolescents with genetic generalized epilepsy: The role of seizure features and affective symptoms 46
Validation of an Italian Questionnaire of Adherence to the Ketogenic Dietary Therapies: iKetoCheck 45
A registry for Dravet syndrome: The Italian experience 44
PGAP2-Related Hyperphosphatasia-Mental Retardation Syndrome: Report of a Novel Patient, Toward a Broadening of Phenotypic Spectrum and Therapeutic Perspectives 44
Case report: KETOLAND the psychoeducation program for ketogenic diet 42
3D facial morphometry in Italian patients affected by Aicardi syndrome 42
Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report 42
Childhood Epilepsy with Centrotemporal Spikes: Clinical and Neuropsychological Outcomes 5 Years after Remission 40
Life Events in the Etiopathogenesis and Maintenance of Restrictive Eating Disorders in Adolescence 39
Sensorimotor Oscillations in Human Infants during an Innate Rhythmic Movement 38
Sensitive period for the plasticity of alpha activity in humans 37
The effect of chronic neuroglycopenia on resting state networks in GLUT1 syndrome across the lifespan 37
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 36
Sporadic and familial glut1ds Italian patients: A wide clinical variability 36
The effects of ketogenic dietary therapies on sleep: A scoping review 35
WISC‐IV intellectual profiles in Italian children with self‐limited epilepsy with centrotemporal spikes 35
The impact of family alexithymia on the severity of restrictive eating disorders in adolescent patients 35
Impact of COVID-19 pandemic in pediatric patients with epilepsy with neuropsychiatric comorbidities: A telemedicine evaluation 35
GLUT1-DS Italian registry: past, present, and future: a useful tool for rare disorders 34
Corrigendum to “Development of a neurologic severity scale for Aicardi Goutières Syndrome” [Mol Genet Metab. 2020 Jun;130(2):153–160. PMID: 32279991] 33
How to Manage Electrical Status Epilepticus in Sleep 32
The vision of dreams: from ontogeny to dream engineering in blindness 30
Unraveling unmet needs in ketogenic dietary services: An ERN EpiCARE survey 29
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study 28
GLUT1DS: focus on motor profile 26
Ketogenic dietary therapies in epilepsy: recommendations of the Italian League against Epilepsy Dietary Therapy Study Group 26
Toward responsible clinical n-of-1 strategies for rare diseases 25
N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward 25
Long-term follow-up of nutritional status in children with GLUT1 Deficiency Syndrome treated with classic ketogenic diet: a 5-year prospective study 25
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 25
Neurobehavioral consequences of continuous spike and waves during slow sleep (CSWS) in a pediatric population: A pattern of developmental hindrance 24
Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study 24
Totale 5.886
Categoria #
all - tutte 29.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 20 2 14 22 8 7 7
2021/2022227 3 0 3 1 9 11 3 10 7 8 31 141
2022/2023891 100 82 11 77 83 60 0 50 395 6 23 4
2023/2024441 64 49 21 26 29 120 13 33 1 15 32 38
2024/20251.779 43 62 39 36 48 173 107 107 458 95 217 394
2025/20262.470 362 236 420 568 673 211 0 0 0 0 0 0
Totale 6.170